SCHEMBL12849043

SCHEMBL12849043

Cn1c(S)nnc1CI

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL391111 0.78
SCHEMBL14557020 0.76
SCHEMBL14112926 0.76
SCHEMBL13865681 0.76
SCHEMBL12716531 0.74 PKM (0.31)
SCHEMBL9176037 0.73
SCHEMBL4388847 0.71 ALDH1A1 (0.41)
SCHEMBL11469968 0.70
SCHEMBL16312316 0.67 CYP1A2 (0.35)
SCHEMBL14557030 0.66

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7906540-B2 Antivirals for HIV and AIDS; compounds are 2-1,2,4-triazolin-5-ones, substituted with aryl(oxy)methyl or benzylamino at position 3; use in combination with antivirals; treating drug resistance infections ROCHE PALO ALTO LLC (US) 2011-03-15 US disclosed
US-20080249151-A1 Non-nucleoside reverse transcriptase inhibitors ROCHE PALO ALTO LLC 2008-10-09 US disclosed